NASDAQ:CASC (CASC) (CASC) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free CASC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$10.02▼$10.0250-Day Range N/A52-Week Range$3.18▼$10.21VolumeN/AAverage Volume1.09 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (CASC) alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About (CASC) Stock (NASDAQ:CASC)Cascadian Therapeutics, Inc., formerly Oncothyreon Inc., is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapeutic products for the treatment of cancer. The Company's clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule human epidermal growth factor receptor (HER) 2 inhibitor. The Company's ONT-10 is a therapeutic vaccine targeting the Mucin 1 peptide antigen (MUC1). The Company is engaged in developing preclinical product candidates in oncology using its Checkpoint kinase 1 (Chk1) kinase inhibitor and protocell technology. The Company completed the evaluation of approximately two dosing cohorts in its Phase Ib trial of ONT-10 in combination with the anti-CD27 T-cell agonist antibody varlilumab in collaboration with other company. The Company has completed Phase I trial of ONT-380, with both dose-escalation and expansion components. The Company has initiated Phase Ib trials of ONT-380.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… CASC Stock News HeadlinesApril 25, 2024 | ca.finance.yahoo.comStart your engines! Mercedes-Benz Toronto Queensway opens featuring North America's first AMG Brand CentreApril 15, 2024 | msn.comChina’s 130-ton reusable rocket engine breaks records during testsApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.April 12, 2024 | finance.yahoo.comGlobal Wooden Satellite Market Size is Expected to Hold a Significant Share By 2033 | CAGR Of 7.3%April 12, 2024 | msn.comAberdeen establishment handed new "requires improvement" food hygiene ratingApril 11, 2024 | msn.comNorthern Ireland Maritime and Offshore Network (NIMO) aims to propel NI’s rich maritime excellenceApril 4, 2024 | msn.comCatching reusable space rockets with tight-wire net, China’s new planApril 3, 2024 | msn.comChina plans to catch its reusable rockets with constricting wires (video)April 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.April 2, 2024 | morningstar.comCascade Copper Corp CASCApril 1, 2024 | msn.comWhy China Might Beat the U.S. Back to the MoonMarch 15, 2024 | msn.comSpaceX CEO Elon Musk Warns Space Rivals To Up Their Game Or End Up 'In the Noise': 'There Isn't Enough To Do Just Launching Satellites'March 8, 2024 | msn.comDoes China need a space data bureau to support its ever-growing satellite networks?March 7, 2024 | msn.comArtistic swimmers want more members to dive inMarch 6, 2024 | msn.comChina’s space agency could own reusable rockets before NASAFebruary 28, 2024 | msn.comChina Wants to Rival NASA With 100 Space Launches in One YearFebruary 27, 2024 | msn.comChina plans 100 launches into spaceFebruary 26, 2024 | msn.comChina’s Space Ambitions Grow With Big Leap in Rocket LaunchesFebruary 26, 2024 | msn.comChina’s Communication Satellite No. 11 Launched Successfully: New Heights in Space ExplorationFebruary 21, 2024 | finance.yahoo.comSetting South Carolina Students Up for Success: Virtual Schools Open for EnrollmentFebruary 15, 2024 | juniorminingnetwork.comCascade Copper Highlights 2023 Exploration Results and 2024 ProgramsFebruary 9, 2024 | news.yahoo.comStitt wants EOSC and CASC to be more 'aggressive' in talks of partnershipFebruary 8, 2024 | news.yahoo.comEOSC Board of Regents pass MOU to share resources with CASCFebruary 8, 2024 | msn.comChina is embarking on a science and exploration program of staggering scaleFebruary 7, 2024 | msn.comChina's deep-space ambitionFebruary 6, 2024 | msn.comChina's New Hyperloop Train Just Hit a Record 387 MPH During TestingFebruary 4, 2024 | msn.comExplore the unforgettable scotch whisky trail in ScotlandSee More Headlines Receive CASC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (CASC) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2017Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryBiotechnology Current SymbolNASDAQ:CASC CUSIP68232410 CIK1412067 Webwww.cascadianrx.com Phone+1-206-8012100FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesChristopher S. Henney Ph.D. (Age 76)Chairman of the Board Scott D. Myers (Age 51)President, Chief Executive Officer, Director Julia Marie Eastland (Age 51)Chief Financial Officer, Vice President - Corporate Development, Secretary Gary W. Christianson (Age 61)Chief Operating Officer Scott Peterson Ph.D. (Age 54)Chief Scientific Officer Robert W. Azelby (Age 49)Director Gwendolyn A. Fyfe M.D. (Age 65)Independent Director Steven P. James (Age 58)Independent Director Ted W. Love M.D. (Age 58)Independent Director Daniel Keith Spiegelman (Age 58)Independent Director More Executives CASC Stock Analysis - Frequently Asked Questions How were (CASC)'s earnings last quarter? (CASC) (NASDAQ:CASC) announced its quarterly earnings results on Wednesday, November, 8th. The biopharmaceutical company reported ($0.28) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.01. During the same quarter last year, the firm earned ($0.09) EPS. What other stocks do shareholders of (CASC) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (CASC) investors own include Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), NIC (EGOV), ALJ Regional (ALJJ), Gran Tierra Energy (GTE) and Transocean (RIG). This page (NASDAQ:CASC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (CASC) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
